ALB and neoplasm: Patients were stratified according to the proposed risk scoring system, which was calculated by combining the prognostic factors of AFP, tumor size and albumin with their corresponding regression coefficients (AFP, 0.514; albumin, 0.518; and tumor size, 0.757) in the multivariate risk proportional regression model for the whole cohort.